Pneumococcal infections risk factors: Difference between revisions
Created page with "__NOTOC__ {{Pneumococcal infections}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References=..." |
m Changes made per Mahshid's request |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pneumococcal infections}} | {{Pneumococcal infections}} | ||
{{CMG}} | |||
==Risk Factors== | |||
The risk of pneumococcal infection is much increased in persons with impaired IgG synthesis, impaired phagocytosis, or defective clearance of pneumococci. In particular, the absence of a functional [[spleen]], through [[congenital asplenia]], [[splenectomy]], or [[sickle-cell disease]] predisposes one to a more severe course of infection ([[Overwhelming post-splenectomy infection]]) and prevention measures are indicated (see [[asplenia]]). ''S. pneumoniae'' expresses different virulence factors on its cell surface and inside the organism. These virulence factors contribute to some of the clinical manifestations during infection with ''S. pneumoniae''. | |||
People whose immune system is compromised, such as those living with [[HIV]], are also at higher risk of pneumococcal disease.<ref name="Siemieniuk 2011">{{cite journal|last=Siemieniuk|first=Reed A.C.|coauthors= Gregson, Dan B.; Gill, M. John |title=The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study|journal=BMC Infectious Diseases|year=2011|month=Nov|volume=11|issue=314|doi=10.1186/1471-2334-11-314|pmid=22078162|url=http://www.biomedcentral.com/1471-2334/11/314|pmc=3226630}}</ref> In [[HIV]] patients with access to treatment, the risk of invasive pneumoccal disease is 0.2%-1% per year and has a fatality rate of 8%.<ref name="Siemieniuk 2011">{{cite journal|last=Siemieniuk|first=Reed A.C.|coauthors= Gregson, Dan B.; Gill, M. John |title=The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study|journal=BMC Infectious Diseases|year=2011|month=Nov|volume=11|issue=314|doi=10.1186/1471-2334-11-314|pmid=22078162|url=http://www.biomedcentral.com/1471-2334/11/314|pmc=3226630}}</ref> | |||
There is an association between pneumococcal pneumonia and [[influenza]].<ref>{{cite journal|author=Walter ND, Taylor TH, Shay DK, ''et al.''|title=Influenza Circulation and the Burden of Invasive Pneumococcal Pneumonia during a Non‐pandemic Period in the United States|journal=Clin Infect Dis|year=2010|volume=50|pages=175–183|doi=10.1086/649208|pmid=20014948|issue=2}}</ref> Damage to the lining of the airways (respiratory epithelium) caused by influenza may facilitate pneumococcal entry and infection. | |||
Other risk factors include [[smoking]], [[injection drug use]], [[Hepatitis C]], and [[COPD]].<ref name="Siemieniuk 2011">{{cite journal|last=Siemieniuk|first=Reed A.C.|coauthors= Gregson, Dan B.; Gill, M. John |title=The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study|journal=BMC Infectious Diseases|year=2011|month=Nov|volume=11|issue=314|doi=10.1186/1471-2334-11-314|pmid=22078162|url=http://www.biomedcentral.com/1471-2334/11/314|pmc=3226630}}</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category: | [[Category:Disease]] | ||
[[Category: | |||
[[Category:Pneumonia]] | |||
[[Category:Bacterial diseases]] | |||
[[Category:Needs overview]] | |||
{{WH}} | |||
{{WS}} | |||
Latest revision as of 18:44, 18 September 2017
|
Pneumococcal infections Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pneumococcal infections risk factors On the Web |
|
American Roentgen Ray Society Images of Pneumococcal infections risk factors |
|
Risk calculators and risk factors for Pneumococcal infections risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Risk Factors
The risk of pneumococcal infection is much increased in persons with impaired IgG synthesis, impaired phagocytosis, or defective clearance of pneumococci. In particular, the absence of a functional spleen, through congenital asplenia, splenectomy, or sickle-cell disease predisposes one to a more severe course of infection (Overwhelming post-splenectomy infection) and prevention measures are indicated (see asplenia). S. pneumoniae expresses different virulence factors on its cell surface and inside the organism. These virulence factors contribute to some of the clinical manifestations during infection with S. pneumoniae.
People whose immune system is compromised, such as those living with HIV, are also at higher risk of pneumococcal disease.[1] In HIV patients with access to treatment, the risk of invasive pneumoccal disease is 0.2%-1% per year and has a fatality rate of 8%.[1]
There is an association between pneumococcal pneumonia and influenza.[2] Damage to the lining of the airways (respiratory epithelium) caused by influenza may facilitate pneumococcal entry and infection.
Other risk factors include smoking, injection drug use, Hepatitis C, and COPD.[1]
References
- ↑ 1.0 1.1 1.2 Siemieniuk, Reed A.C. (2011). "The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study". BMC Infectious Diseases. 11 (314). doi:10.1186/1471-2334-11-314. PMC 3226630. PMID 22078162. Unknown parameter
|coauthors=ignored (help); Unknown parameter|month=ignored (help) - ↑ Walter ND, Taylor TH, Shay DK; et al. (2010). "Influenza Circulation and the Burden of Invasive Pneumococcal Pneumonia during a Non‐pandemic Period in the United States". Clin Infect Dis. 50 (2): 175–183. doi:10.1086/649208. PMID 20014948.